Results 91 to 100 of about 1,098,707 (256)
Journal of Respiration, 2021 Chronic thromboembolic disease (CTEPH) is one of the causes for developing pulmonary hypertension (PH). PH is characterized by an increase in pulmonary vascular pressure and resistance, ultimately leading to chronic overload.
Javier Enrique Fajardo-Rivero +7 more
doaj +1 more source
Physiological shear stress suppresses apoptosis in human pulmonary microvascular endothelial cells
Physiological Reports, Volume 13, Issue 6, March 2025.Abstract Physiological shear stress contributes to maintaining endothelial cell homeostasis, including suppression of apoptosis. In the pulmonary circulation, diseases such as pulmonary embolism and pulmonary hypertension result in alterations in shear stress. Shear stress has been reported to suppress endothelial apoptosis through phosphatidylinositol
Simin Yan +8 more
wiley +1 more source
Кардиоваскулярная терапия и профилактика, 2019 Improving the methods of diagnosis, therapy and surgical treatment of chronic thromboembolic pulmonary hypertension (CTEPH) provides a complete cure in most cases.
D. A. Feshchenko +6 more
doaj +1 more source
Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia
The Clinical Respiratory Journal, Volume 19, Issue 2, February 2025.This study describes the treatment patterns among ambulatory patients with pulmonary hypertension (PH) in Colombia, from a population‐based drug‐dispensing database between 2022 and 2023. It found that patients with PH from Colombia were treated predominantly with monotherapy of calcium channel blockers and phosphodiesterase 5 inhibitors, with an ...
Manuel Machado‐Duque +8 more
wiley +1 more source
Health-related quality of life in patients with pulmonary arterial hypertension [PDF]
, 2005 BACKGROUND: Improved outcomes with expanding treatment options for patients with pulmonary arterial hypertension present the opportunity to consider additional end-points in approaching therapy, including factors that influence health-related quality of ...
Christine Archer-Chicko +9 more
core +2 more sources
Improvement in the pulmonary circulation following pulmonary thromboendarterectomy [PDF]
Heart, 2001 Chronic pulmonary thromboembolic disease is an insidious, life threatening condition that develops as a long term complication of the incomplete resolution of pulmonary embolism. Patients present with progressive breathlessness on exertion and the prognosis is poor owing to the development of pulmonary hypertension, with less than 30% five year ...
R, Sayeed, R, Coulden, J, Dunning
openaire +2 more sources
The Siberian Journal of Clinical and Experimental Medicine, 2023 Aim: To study the clinical and functional features, as well as intra- and postoperative indicators of patients with chronic thromboembolic pulmonary hypertension (CTEPH) with the development of negative dynamics of cognitive status in the early ...
A. Klinkova +8 more
semanticscholar +1 more source
Isolated pulmonary valve endocarditis with rapid progression: a case report and literature review
Journal of Cardiothoracic Surgery, 2021 Background Isolated pulmonary valve endocarditis (IPE) is rare, accounting for 1.5–2% of all cases of infective endocarditis. Herein, we describe a case of isolated pulmonary valve endocarditis with rapid progression in a 28-year-old male.
Ming-Xuan Zhang +6 more
doaj +1 more source
Risk factors for pulmonary thromboendarterectomy
The Journal of Thoracic and Cardiovascular Surgery, 1990 Pulmonary thromboendarterectomy is being performed with increasing frequency for incapacitating pulmonary hypertension caused by chronic large-vessel pulmonary embolism. However, patient-related risk factors and procedural complications associated with morbidity and mortality have not been fully defined. From Oct.
P O, Daily +4 more
openaire +2 more sources
Craniofacial Involvement of Mucormycosis: A Single‐Center Experience of 57 Cases From Shiraz, Iran
Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2025, Issue 1, 2025.Background: The incidence of mucormycosis surged significantly during the COVID‐19 pandemic, particularly among patients with diabetes mellitus (DM), a history of corticosteroid use, or immunosuppression. In Iran, the heightened prevalence of this opportunistic fungal infection underscored the critical importance of timely and comprehensive treatment ...
Darioush Naddaffard +9 more
wiley +1 more source